Gut microbiome-focused dietary interventions in weight management: causal evidence, precision nutrition and emerging gut-targeted therapies

Purpose This study aims to critically evaluate dietary and gut-directed strategies for weight management, distinguishing association from causation while integrating fibre structure, biomaterials, precision nutrition, microbial therapeutics and glucagon-like peptide-1 receptor agonist (GLP-1 RA) care. Design/methodology/approach A targeted narrative synthesis of human interventions, mechanistic studies, consensus statements, systematic reviews and preclinical studies was assessed for design, replication, clinical relevance and causal mediation. Findings Microbiome changes alone do not establish clinically meaningful mechanisms. Causal support is strongest from transfer experiments, short-term human faecal microbiota transplantation, controlled feeding and targeted metabolite delivery, although effects are often transient. Whole-food diets rich in diverse fibres, resistant starch, minimally processed plants and fermented foods remain the most mature strategy. Prebiotic effects vary with structure, dose, food matrix and host ecology; fibre–clay hybrids remain preclinical. Precision nutrition using multi-omics and machine learning is advancing, but external validation and superior weight-loss outcomes remain limited. Live biotherapeutics, engineered microbes, postbiotics and faecal microbiota transplantation differ in readiness, safety and regulation. Research limitations/implications Future trials require standardised outcomes, direct metabolomics, shotgun metagenomics, longer follow-up and prespecified mediation analyses. Practical implications Care should remain food-first, culturally adaptable and integrated with obesity therapies. During GLP-1 RA treatment, gradual fibre titration, hydration, smaller meals and symptom-specific foods may improve tolerability, although direct evidence is limited. Social implications Public health policy should improve access to minimally processed, fibre-rich foods and avoid deterministic microbiome claims. Originality/value This review provides an evidence hierarchy linking fibre structure, biomaterials, precision nutrition and microbial therapeutics to clinical weight-management decisions.

Authors

Institutions

Publication Details

Journal
Nutrition & Food Science
Published
2026-09-15
DOI
https://doi.org/10.1108/nfs-05-2026-0239
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Gut microbiome-focused dietary interventions in weight management: causal evidence, precision nutrition and emerging gut-targeted therapies

Nga Chong Lisa Cheng, E. Lim, Chi Eung Danforn Lim
Nutrition & Food Science
Gut microbiota and health
article

Gut microbiome-focused dietary interventions in weight management: causal evidence, precision nutrition and emerging gut-targeted therapies

Nga Chong Lisa Cheng, E. Lim, Chi Eung Danforn Lim
article en

Abstract

Purpose This study aims to critically evaluate dietary and gut-directed strategies for weight management, distinguishing association from causation while integrating fibre structure, biomaterials, precision nutrition, microbial therapeutics and glucagon-like peptide-1 receptor agonist (GLP-1 RA) care. Design/methodology/approach A targeted narrative synthesis of human interventions, mechanistic studies, consensus statements, systematic reviews and preclinical studies was assessed for design, replication, clinical relevance and causal mediation. Findings Microbiome changes alone do not establish clinically meaningful mechanisms. Causal support is strongest from transfer experiments, short-term human faecal microbiota transplantation, controlled feeding and targeted metabolite delivery, although effects are often transient. Whole-food diets rich in diverse fibres, resistant starch, minimally processed plants and fermented foods remain the most mature strategy. Prebiotic effects vary with structure, dose, food matrix and host ecology; fibre–clay hybrids remain preclinical. Precision nutrition using multi-omics and machine learning is advancing, but external validation and superior weight-loss outcomes remain limited. Live biotherapeutics, engineered microbes, postbiotics and faecal microbiota transplantation differ in readiness, safety and regulation. Research limitations/implications Future trials require standardised outcomes, direct metabolomics, shotgun metagenomics, longer follow-up and prespecified mediation analyses. Practical implications Care should remain food-first, culturally adaptable and integrated with obesity therapies. During GLP-1 RA treatment, gradual fibre titration, hydration, smaller meals and symptom-specific foods may improve tolerability, although direct evidence is limited. Social implications Public health policy should improve access to minimally processed, fibre-rich foods and avoid deterministic microbiome claims. Originality/value This review provides an evidence hierarchy linking fibre structure, biomaterials, precision nutrition and microbial therapeutics to clinical weight-management decisions.

Nutrition & Food Science
Translational Research Institute (AU)
Openalex Percentile: Top 18%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.